TORONTO, March 20, 2014 /CNW/ - Ontario's need for lifesaving drugs made
from human plasma far exceeds our ability to produce it. That's why
Ontario's health care system purchases hundreds of millions of dollars
of these products from American companies that compensate plasma
donors. No country in the world is self-sufficient in the production of
these products from a solely voluntary donor base. This is not about
collecting blood or plasma for transfusion, but rather plasma that will
be manufactured into critical pharmaceutical products for patients with
life threatening diseases.
Today, Health Minister Deb Matthews introduced legislation aiming to
stop Ontario companies from supplying these products.
"Minister Matthews is ignoring evidence and distorting facts to the
detriment of patients, the health care system, and our economy. She is
shutting down an Ontario company in favour of foreign competition."
Said Barzin Bahardoust, CEO of Canadian Plasma Resources.
"This legislation means that Ontario's patients will remain dependent on
American companies for these lifesaving drugs," he continued. It is
irresponsible to design a Health Care system over reliant on paid
donors abroad, where we have no regulatory oversight."
The Canadian Hemophilia Society said in its statement that it sees "the
decision by the Government of Ontario not to allow these centres to
open to be a reaction to public opinion, not a decision based on
science or ethics. Over the last 20 years, the plasma industry has
developed well-documented and effective procedures to ensure that
plasma can be collected safely, both for the donors and the
In its 2013 report to Canadians, Canadian Blood Services, the
organization that collects whole blood and plasma for transfusion, and
purchases plasma protein therapies from private companies, stated:
"self-sufficiency is not operationally or economically feasible in a
volunteer, non-remunerated model."
SOURCE: Canadian Plasma Resources
For further information:
Dr. Barzin Bahardoust
CEO, Canadian Plasma Resources